comparemela.com

Latest Breaking News On - Tarsus pharmaceuticals inc - Page 1 : comparemela.com

'The Octane Guy' Plans Big - Orange County Business Journal

'The Octane Guy' Plans Big - Orange County Business Journal
ocbj.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ocbj.com Daily Mail and Mail on Sunday newspapers.

Boston
Massachusetts
United-states
Orange-county
California
New-york
Newport-beach
Long-island
Denver
Colorado
Irvine
Jim-mazzo

Tarsus to Participate in Upcoming Investor Conferences

IRVINE, Calif., May 29, 2024 Tarsus Pharmaceuticals, Inc. , whose mission is to focus on unmet needs and apply proven science and new technology to revolutionize treatment for patients, starting.

United-states
Jeff-farrow
David-nakasone
Aziz-mottiwala
Bobak-azamian
Adrienne-kemp
Nasdaq
Corporate-communications
Tarsus-pharmaceuticals-inc
Chief-financial
Chief-strategy-officer
Chief-commercial-officer

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Receives $49.88 Consensus Price Target from Brokerages

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has been given a consensus rating of “Moderate Buy” by the eight brokerages that are presently covering the firm, MarketBeat.com reports. One investment analyst has rated the stock with a hold recommendation and seven have given a buy recommendation to the company. The average 12-month target price […]

United-states
Bryan-wahl
Bobakr-azamian
Artisan-partners-limited-partnership
Hedge-funds-weigh-in-on-tarsus-pharmaceuticals
Barclays
Securities-exchange-commission
Tarsus-pharmaceuticals-stock-down
Jennison-associates
News-ratings-for-tarsus-pharmaceuticals-daily
Jefferies-financial-group
Pricet-rowe-associates-inc

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Given Consensus Recommendation of "Moderate Buy" by Analysts

Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS – Get Free Report) has received an average recommendation of “Moderate Buy” from the eight analysts that are covering the firm, Marketbeat reports. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating on the company. The average twelve-month price objective among brokerages […]

United-states
Bobakr-azamian
Bryan-wahl
Nasdaq
Vanguard-group-inc
Goldman-sachs-group
Tarsus-pharmaceuticals-trading-down
News-ratings-for-tarsus-pharmaceuticals-daily
Healthcare-of-ontario-pension-plan-trust-fund
Institutional-trading-of-tarsus-pharmaceuticals
Tarsus-pharmaceuticals-inc
Tarsus-pharmaceuticals

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Down 3.6%

Tarsus Pharmaceuticals (NASDAQ:TARS) Trading Down 3.6%
wkrb13.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wkrb13.com Daily Mail and Mail on Sunday newspapers.

United-states
China
Bobakr-azamian
Bryan-wahl
Zurcher-kantonalbank-zurich-cantonalbank
Ieq-capital
Barclays
Goldman-sachs-group
Tarsus-pharmaceuticals-company-profile
Tarsus-pharmaceuticals
Jefferies-financial-group
Tarsus-pharmaceuticals-stock-performance
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.